BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1980167)

  • 1. Immunohistochemical investigation and northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri.
    Brumm C; Rivière A; Wilckens C; Löning T
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(6):477-84. PubMed ID: 1980167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma.
    Ter Harmsel B; Smedts F; Kuijpers J; Jeunink M; Trimbos B; Ramaekers F
    J Pathol; 1996 May; 179(1):26-30. PubMed ID: 8691340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of co-overexpression of bcl-2 and c-erbB-2/neu in uterine cervix carcinomas and premalignant lesions.
    Protrka Z; Arsenijević S; Arsenijević P; Mitrović S; Stanković V; Milosavljević M; Nedović J; Kastratović T; Durić J
    Med Glas (Zenica); 2012 Aug; 9(2):248-55. PubMed ID: 22926359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
    Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
    Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium.
    Toda T; Sadi AM; Egawa H; Atari E; Qureshi B; Nagai Y
    Histopathology; 1998 Mar; 32(3):257-63. PubMed ID: 9568512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease.
    Berchuck A; Rodriguez G; Kinney RB; Soper JT; Dodge RK; Clarke-Pearson DL; Bast RC
    Am J Obstet Gynecol; 1991 Jan; 164(1 Pt 1):15-21. PubMed ID: 1670908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nectin-1 expression in the normal and neoplastic human uterine cervix.
    Guzman G; Oh S; Shukla D; Valyi-Nagy T
    Arch Pathol Lab Med; 2006 Aug; 130(8):1193-5. PubMed ID: 16879022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DeltaNp63 protein expression in uterine cervical and endometrial cancers.
    Lin Z; Liu M; Li Z; Kim C; Lee E; Kim I
    J Cancer Res Clin Oncol; 2006 Dec; 132(12):811-6. PubMed ID: 16804722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laminin immunostaining in hyperplastic, dysplastic, and neoplastic lesions of the endometrium and uterine cervix.
    Vogel HP; Mendelsohn G
    Obstet Gynecol; 1987 May; 69(5):794-9. PubMed ID: 2437505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
    Onuma K; Dabbs DJ; Bhargava R
    Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas].
    Milde-Langosch K; Wilckens C; Brack T; Löning T
    Verh Dtsch Ges Pathol; 1991; 75():363-5. PubMed ID: 1724842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma.
    Smedts F; Ramaekers F; Leube RE; Keijser K; Link M; Vooijs P
    Am J Pathol; 1993 Feb; 142(2):403-12. PubMed ID: 7679549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CAAT enhancer binding protein beta (C/EBP beta) in cervix and endometrium.
    Arnett B; Soisson P; Ducatman BS; Zhang P
    Mol Cancer; 2003 Apr; 2():21. PubMed ID: 12713669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors.
    Saegusa M; Hashimura M; Hara A; Okayasu I
    J Pathol; 2000 Apr; 190(5):554-63. PubMed ID: 10727981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
    Ohwada M; Suzuki M; Tamada T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions.
    Nakamura T; Nomura S; Sakai T; Nariya S
    Hum Pathol; 1997 Mar; 28(3):309-15. PubMed ID: 9042795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
    Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
    Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
    Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
    Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.